細胞免疫療法全球市場規模調查：按治療類型、適應症、最終用途和地區預測（2022-2028 年）

先進細胞療法的開發、癌症患病率的上升以及主要參與者增加研發投資是推動細胞免疫療法市場增長的關鍵因素。 .

然而，細胞免疫治療產品的高製造成本預計將抑制市場增長。

本報告研究和分析全球細胞免疫治療市場，並提供包括市場動態、行業分析、市場分析和競爭信息在內的系統信息。

內容

第 1 章執行摘要

第 2 章全球細胞免疫治療市場定義和範圍

第三章全球細胞免疫治療市場動態

• 細胞免疫治療市場影響分析（2020-2028）

第 4 章全球細胞免疫治療市場行業分析

• 波特五力模型
• PEST 分析
• 招商引資模式
• 分析師的建議和結論
• 最佳投資機會
• 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

• 評估 COVID-19 對行業的整體影響
• COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球細胞免疫治療市場：按治療類型分類

• 市場快照
• 全球細胞免疫療法市場表現 - 潛力分析：按治療類型
• 全球細胞免疫療法市場估計和預測（百萬美元）（2018-2028 年）：按治療類型
• 細胞免疫治療市場，細分分析
  • CAR-T 細胞療法
  • 樹突狀細胞療法
  • NK細胞療法
  • TIL 療法
  • 其他

第 7 章全球細胞免疫治療市場：按適應症分類

• 市場快照
• 全球細胞免疫療法市場表現 - 潛力分析：按適應症
• 全球細胞免疫治療市場估計和預測（百萬美元）（2018-2028）：按適應症
• 細胞免疫治療市場，細分分析
  • B細胞惡性腫瘤
  • 前列腺癌
  • 肝癌
  • 腎細胞癌
  • 其他

第 8 章全球細胞免疫治療市場：按最終用途分類

• 市場快照
• 全球細胞免疫療法市場表現 - 潛力分析：按最終用途分類
• 全球細胞免疫療法市場估計和預測（百萬美元）（2018-2028 年）：按最終用途
• 細胞免疫治療市場，細分分析
  • 醫院
  • 癌症研究所
  • 其他

第 9 章全球細胞免疫治療市場，區域分析

• 區域市場概況
• 北美
  • 美國
  • 加拿大
• 歐洲快照
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 意大利
  • 其他歐洲
• 亞太地區概況
  • 中國
  • 印度
  • 日本
  • 澳大利亞
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲快照
  • 巴西
  • 墨西哥
• 世界其他地區

第 10 章衝突信息

• 主要市場策略
• 公司簡介
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Gilead Sciences Inc.(Kite Pharma)
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • GlaxoSmithKline plc.
  • AstraZeneca
  • Pfizer Inc.
  • Johnson & Johnson
  • Celyad

第11章 調查流程

Global Cellular Immunotherapy Market is valued at approximately XX in 2021 and is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2022-2028.Cellular immunotherapy, also known as adoptive cell therapy, is a type of cancer treatment that employs immune system cells.The development of advanced cell-based therapies, the rising prevalence of cancer, and increased R&D investment by key companies are some of the major factors driving market growth. Furthermore, the increasing number of product approvals and growing adoption of these therapies for cancer treatment is driving market growth.According to Globocan estimates, an estimated 19.2 million new cancer cases were reported worldwide in 2020, with this figure expected to rise to 24.5 million by 2030. Cancer is expected to kill 10 million people by 2020. According to Cancer Research UK, over 375,000 new cancer cases are reported in the United Kingdom each year. Furthermore, according to WHO estimates, two-thirds of the world's population aged 60 and up lives in developing countries. The most common factor that increases the risk of cancer is ageing. As a result, the rising geriatric population is expected to increase in prevalence over the forecast period, driving demand for cellular immunotherapies.However, the high cost of manufacturing cellular immunotherapy products is expected to limit growth.

The key regions considered for the global Cellular Immunotherapy marketstudy includeAsia Pacific, North America, Europe, Latin America, and Rest of the World.The Asia Pacific region is predicted to grow at the fastest rate due to unexplored prospects and increased awareness about cellular immunotherapy, as well as quickly building healthcare infrastructure. Because of its well-established healthcare infrastructure, availability of advanced therapies, high disposable income, and high per capita healthcare expenditure, North America dominated the market in terms of revenue in 2021.

Major market players included in this report are:

Bristol-Myers Squibb Company

Novartis AG

Gilead Sciences Inc. (Kite Pharma)

F. Hoffmann-La Roche Ltd

Merck KGaA

GlaxoSmithKline plc.

AstraZeneca

Pfizer Inc.

Johnson & Johnson

Celyad

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

ByTherapy Type:

CAR T Cell Therapy

Dendritic Cell Therapy

NK Cell Therapy

TIL Therapy

Others

ByIndication:

B-cell Malignancies

Prostate Cancer

Liver Cancer

Renal Cell Carcinoma

Others

ByEnd-use:

Hospitals

Cancer Institutes

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Cellular Immunotherapy Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
  • 1.2.1. Cellular Immunotherapy Market, by Region, 2020-2028 (USD Million)
  • 1.2.2. Cellular Immunotherapy Market, by Therapy Type,2020-2028 (USD Million)
  • 1.2.3. Cellular Immunotherapy Market, by Indication, 2020-2028 (USD Million)
  • 1.2.4. Cellular Immunotherapy Market, by End-use, 2020-2028 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Cellular Immunotherapy Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Cellular Immunotherapy Market Dynamics

• 3.1. Cellular Immunotherapy Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising Prevalence of Cancer
    • 3.1.1.2. Technological Advancement in Developing Target-Based Anti-cancer Therapies
  • 3.1.2. Market Challenges
    • 3.1.2.1. The high cost of cellular immunotherapies
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Increasing research and successful clinical trials in cellular immunotherapy

Chapter 4. Global Cellular Immunotherapy Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Cellular Immunotherapy Market, by Therapy Type

• 6.1. Market Snapshot
• 6.2. Global Cellular Immunotherapy Market by Therapy Type, Performance - Potential Analysis
• 6.3. Global Cellular Immunotherapy Market Estimates & Forecasts by Therapy Type, 2018-2028 (USD Million)
• 6.4. Cellular Immunotherapy Market, Sub Segment Analysis
  • 6.4.1. CAR T Cell Therapy
  • 6.4.2. Dendritic Cell Therapy
  • 6.4.3. NK Cell Therapy
  • 6.4.4. TIL Therapy
  • 6.4.5. Others

Chapter 7. Global Cellular Immunotherapy Market, by Indication

• 7.1. Market Snapshot
• 7.2. Global Cellular Immunotherapy Market by Indication, Performance - Potential Analysis
• 7.3. Global Cellular Immunotherapy Market Estimates & Forecasts by Indication, 2018-2028 (USD Million)
• 7.4. Cellular Immunotherapy Market, Sub Segment Analysis
  • 7.4.1. B-cell Malignancies
  • 7.4.2. Prostate Cancer
  • 7.4.3. Liver Cancer
  • 7.4.4. Renal Cell Carcinoma
  • 7.4.5. Others

Chapter 8. Global Cellular Immunotherapy Market, by End-use

• 8.1. Market Snapshot
• 8.2. Global Cellular Immunotherapy Market by End-use, Performance - Potential Analysis
• 8.3. Global Cellular Immunotherapy Market Estimates & Forecasts by End-use, 2018-2028 (USD Million)
• 8.4. Cellular Immunotherapy Market, Sub Segment Analysis
  • 8.4.1. Hospitals
  • 8.4.2. Cancer Institutes
  • 8.4.3. Others

Chapter 9. Global Cellular Immunotherapy Market, Regional Analysis

• 9.1. Cellular Immunotherapy Market, Regional Market Snapshot
• 9.2. North America Cellular Immunotherapy Market
  • 9.2.1. U.S. Cellular Immunotherapy Market
    • 9.2.1.1. Therapy Type breakdown estimates & forecasts, 2018-2028
    • 9.2.1.2. Indication breakdown estimates & forecasts, 2018-2028
    • 9.2.1.3. End-use breakdown estimates & forecasts, 2018-2028
  • 9.2.2. Canada Cellular Immunotherapy Market
• 9.3. Europe Cellular Immunotherapy Market Snapshot
  • 9.3.1. U.K. Cellular Immunotherapy Market
  • 9.3.2. Germany Cellular Immunotherapy Market
  • 9.3.3. France Cellular Immunotherapy Market
  • 9.3.4. Spain Cellular Immunotherapy Market
  • 9.3.5. Italy Cellular Immunotherapy Market
  • 9.3.6. Rest of Europe Cellular Immunotherapy Market
• 9.4. Asia-Pacific Cellular Immunotherapy Market Snapshot
  • 9.4.1. China Cellular Immunotherapy Market
  • 9.4.2. India Cellular Immunotherapy Market
  • 9.4.3. Japan Cellular Immunotherapy Market
  • 9.4.4. Australia Cellular Immunotherapy Market
  • 9.4.5. South Korea Cellular Immunotherapy Market
  • 9.4.6. Rest of Asia Pacific Cellular Immunotherapy Market
• 9.5. Latin America Cellular Immunotherapy Market Snapshot
  • 9.5.1. Brazil Cellular Immunotherapy Market
  • 9.5.2. Mexico Cellular Immunotherapy Market
• 9.6. Rest of The World Cellular Immunotherapy Market

Chapter 10. Competitive Intelligence

• 10.1. Top Market Strategies
• 10.2. Company Profiles
  • 10.2.1. Bristol-Myers Squibb Company
    • 10.2.1.1. Key Information
    • 10.2.1.2. Overview
    • 10.2.1.3. Financial (Subject to Data Availability)
    • 10.2.1.4. Indication Summary
    • 10.2.1.5. Recent Developments
  • 10.2.2. Novartis AG
  • 10.2.3. Gilead Sciences Inc. (Kite Pharma)
  • 10.2.4. F. Hoffmann-La Roche Ltd
  • 10.2.5. Merck KGaA
  • 10.2.6. GlaxoSmithKline plc.
  • 10.2.7. AstraZeneca
  • 10.2.8. Pfizer Inc.
  • 10.2.9. Johnson & Johnson
  • 10.2.10. Celyad

Chapter 11. Research Process

• 11.1. Research Process
  • 11.1.1. Data Mining
  • 11.1.2. Analysis
  • 11.1.3. Market Estimation
  • 11.1.4. Validation
  • 11.1.5. Publishing
• 11.2. Research Attributes
• 11.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Cellular Immunotherapy Market, report scope
• TABLE 2. Global Cellular Immunotherapy Market estimates & forecasts by Region 2018-2028 (USD Million)
• TABLE 3. Global Cellular Immunotherapy Market estimates & forecasts by Therapy Type 2018-2028 (USD Million)
• TABLE 4. Global Cellular Immunotherapy Market estimates & forecasts by Indication 2018-2028 (USD Million)
• TABLE 5. Global Cellular Immunotherapy Market estimates & forecasts by End-use 2018-2028 (USD Million)
• TABLE 6. Global Cellular Immunotherapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 7. Global Cellular Immunotherapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 8. Global Cellular Immunotherapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 9. Global Cellular Immunotherapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 10. Global Cellular Immunotherapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 11. Global Cellular Immunotherapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 12. Global Cellular Immunotherapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 13. Global Cellular Immunotherapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 14. Global Cellular Immunotherapy Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 15. Global Cellular Immunotherapy Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 16. U.S. Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 17. U.S. Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 18. U.S. Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 19. Canada Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 20. Canada Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 21. Canada Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 22. UK Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 23. UK Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 24. UK Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 25. Germany Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 26. Germany Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 27. Germany Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 28. RoE Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 29. RoE Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 30. RoE Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 31. China Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 32. China Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 33. China Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 34. India Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 35. India Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 36. India Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 37. Japan Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 38. Japan Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 39. Japan Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 40. RoAPAC Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 41. RoAPAC Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 42. RoAPAC Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 43. Brazil Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 44. Brazil Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 45. Brazil Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 46. Mexico Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 47. Mexico Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 48. Mexico Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 49. RoLA Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 50. RoLA Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 51. RoLA Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 52. Row Cellular Immunotherapy Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 53. Row Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 54. Row Cellular Immunotherapy Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 55. List of secondary sources, used in the study of global Cellular Immunotherapy Market
• TABLE 56. List of primary sources, used in the study of global Cellular Immunotherapy Market
• TABLE 57. Years considered for the study
• TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Cellular Immunotherapy Market, research methodology
• FIG 2. Global Cellular Immunotherapy Market, market estimation techniques
• FIG 3. Global market size estimates & forecast methods
• FIG 4. Global Cellular Immunotherapy Market, key trends 2021
• FIG 5. Global Cellular Immunotherapy Market, growth prospects 2022-2028
• FIG 6. Global Cellular Immunotherapy Market, porters 5 force model
• FIG 7. Global Cellular Immunotherapy Market, pest analysis
• FIG 8. Global Cellular Immunotherapy Market, value chain analysis
• FIG 9. Global Cellular Immunotherapy Market by segment, 2018 & 2028 (USD Million)
• FIG 10. Global Cellular Immunotherapy Market by segment, 2018 & 2028 (USD Million)
• FIG 11. Global Cellular Immunotherapy Market by segment, 2018 & 2028 (USD Million)
• FIG 12. Global Cellular Immunotherapy Market by segment, 2018 & 2028 (USD Million)
• FIG 13. Global Cellular Immunotherapy Market by segment, 2018 & 2028 (USD Million)
• FIG 14. Global Cellular Immunotherapy Market, regional snapshot 2018 & 2028
• FIG 15. North America Cellular Immunotherapy Market 2018 & 2028 (USD Million)
• FIG 16. Europe Cellular Immunotherapy Market 2018 & 2028 (USD Million)
• FIG 17. Asia Pacific Cellular Immunotherapy Market 2018 & 2028 (USD Million)
• FIG 18. Latin America Cellular Immunotherapy Market 2018 & 2028 (USD Million)
• FIG 19. Global Cellular Immunotherapy Market, company market share analysis (2021)